GeneDx Holdings Corp. - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for GeneDx Holdings Corp. (WGS) is 3.24B

According to GeneDx Holdings Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.24B. This represents a change of 20.23% compared to the average of 2.69B of the last 4 quarters.

GeneDx Holdings Corp. (WGS) Historical Enterprise Value (quarterly & annually)

How has WGS Enterprise Value performed in the past?

The mean historical Enterprise Value of GeneDx Holdings Corp. over the last ten years is 1.12B. The current 3.24B Enterprise Value has changed 28.74% with respect to the historical average. Over the past ten years (40 quarters), WGS's Enterprise Value was at its highest in in the December 2025 quarter at 3.54B. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

GeneDx Holdings Corp. (WGS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GeneDx Holdings Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GeneDx Holdings Corp. (WGS) Average Enterprise Value

How has WGS Enterprise Value performed in the past?

The current Enterprise Value of GeneDx Holdings Corp. (WGS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

GeneDx Holdings Corp. (WGS) Enterprise Value vs. Peers

How is WGS’s Enterprise Value compared to its peers?

GeneDx Holdings Corp.’s Enterprise Value is less than Hinge Health, Inc. (7.05B), less than Kymera Therapeutics, Inc. (9.70B), less than TransMedics Group, Inc. (3.39B), less than Viking Therapeutics, Inc. (3.30B), less than Oscar Health, Inc. (4.65B), less than Immunovant, Inc. (6.97B), greater than Privia Health Group, Inc. (-400935411406.00), less than Crinetics Pharmaceuticals, Inc. (8.99B), less than Option Care Health, Inc. (4.74B), greater than NewAmsterdam Pharma Company N.V. (2.14B),

Build a custom stock screener for GeneDx Holdings Corp. (WGS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeneDx Holdings Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GeneDx Holdings Corp. (WGS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GeneDx Holdings Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.